期刊文献+

自然杀伤T细胞的肿瘤免疫治疗

Natural killer T cell-based immunotherpy for cancer
原文传递
导出
摘要 体内外实验表明,静脉注入α-半乳糖神经酰胺(α—GalCer)及α-GalCer荷载的树突状细胞(DC)在体内均可活化自然杀伤T(NKT)细胞,可达到抗肿瘤免疫治疗作用;过继输入体外培养、扩增的NKT细胞,也可达到此治疗目的。 Administrating intravenously α-GalCer and α-GalCer-pulsed dendritic cell that can activate natural killer T(NKT) cells in vivo, and adoptive transfer of in vitro and proliferated NKT ceils could achieve anti-tumor immunotherpy effects.
出处 《国际肿瘤学杂志》 CAS 2010年第2期119-122,共4页 Journal of International Oncology
关键词 肿瘤 免疫疗法 α-半乳糖神经酰胺 Neoplasms Immunotherpy Alpha- galaetosyleeramide
  • 相关文献

参考文献19

  • 1Nadas J,Li C,Wang PC.Computational structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK.J Chem Inf Model,2009,49(2):410-423.
  • 2Chang YJ,Huang JR,Tsai YC,et al.Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.Proc Natl Acad Sci USA,2007,104(25):10299-10304.
  • 3Fujii S,Shimizu K,Hemmi H,et al.Innate ValphaI4(+)natural killer T cells mature dendritic cells,leading to strong adaptive immunity.Immunol Rev,2007,220:183-198.
  • 4Wesley JD,Robbing SH,Sidobre S,et al.Cutting edge:IFN-gamma signaling to macrophages is required for optimal Valphal4i NK T/NK ceU cross-talk.J Immunol,2005,174(7):3864-3868.
  • 5Teng MW,Yue S,Sharkey J,et al.CD1d activation and blockade:anew antitumor strategy,J Immunol,2009,182(6):3366-3371.
  • 6Hong C,Lee H,Park YK,et al.Regulation of secondary antigen-specific CDS (+) T-cell responses by natural killer T cells.Cancer Res,2009,69(10):4301-4308.
  • 7Bricard G,Cesson V,Devevre E,et al.Enrichment of human CD4^+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.J Immunol,2009,182(8):5140-5151.
  • 8Moiling JW,Moreno M,van der Vliet HJ,et al.Invariant natural killer T cells and immunotherapy of cancer.Clin Immunol,2008,129 (2):182-194.
  • 9Swann JB,Coquet JM,Smyth MJ,et al.CD 1-restricted T cells andtumor immunity.Curr Top Microbiol Immunol,2007,314-293-323.
  • 10Fukushima S,Hirata S,Motomura Y,et al.Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.J Chem Inf Model,2009,32(3):219-231.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部